Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Shanthi Kanthala"'
Autor:
Shanthi Kanthala, Seetharama D. Jois, Sandeep Pallerla, Rushikesh Sable, Yong-Yu Liu, Sitanshu S. Singh
Publikováno v:
Oncotarget
// Shanthi P. Kanthala 1 , Yong-Yu Liu 1 , Sitanshu Singh 1 , Rushikesh Sable 1 , Sandeep Pallerla 1 and Seetharama D. Jois 1 1 Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, Monroe LA 71201, USA Correspondence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::156d86bfb02b033403c89313fbbb6b4c
https://doi.org/10.18632/oncotarget.19013
https://doi.org/10.18632/oncotarget.19013
Autor:
Subbu S. Venkatraman, Soo-Ryoon Ryoo, Kaylin M. McMahon, Yue Li, C. Shad Thaxton, Shanthi Kanthala, Vikas Nandwana, Vinayak P. Dravid, Jonathan S. Rink
Publikováno v:
Chemistry of Materials. 29:2276-2282
We report the development of potential theranostic agents for cardiovascular disease that are based on high-density lipoprotein-like magnetic nanostructures (HDL-MNS). The HDL-MNS offer prospects for diagnosis via noninvasive magnetic resonance imagi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c42add72cabca27b1010dfe586aa139
https://doi.org/10.1021/acs.chemmater.6b05357
https://doi.org/10.1021/acs.chemmater.6b05357
Autor:
Soo-Ryoon Ryoo, Brian M. Hoffman, Ambrish Kumar, Avinash Sharma, Sierin Lim, Vinayak P. Dravid, Fernando C. Castro, Vikas Nandwana, Shanthi Kanthala, Yuan Li
Publikováno v:
RSC Advances. 7:34892-34900
We report the development of a self-assembling protein nanocage as a contrast agent for magnetic resonance imaging (MRI). The protein nanocage is derived from genetically engineered ferritin from Archaeoglobus fulgidus (AfFtnAA). Iron (Fe) was loaded
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::251ab0fa50b0eff627239685540da0dd
https://doi.org/10.1039/c7ra05681h
https://doi.org/10.1039/c7ra05681h
Publikováno v:
Protein Expression and Purification. 125:26-33
Overexpression of human epidermal growth factor receptor 2 (HER2/ErbB2/Neu) results in ligand independent activation of kinase signaling and is found in about 30% of human breast cancers, and is correlated with a more aggressive tumor phenotype. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a50694947159098d9d2784f0c422764
https://doi.org/10.1016/j.pep.2015.09.001
https://doi.org/10.1016/j.pep.2015.09.001
Autor:
Vikas Nandwana, Mrinmoy De, Soo-Ryoon Ryoo, Stanley S. Chou, Pottumarthi V. Prasad, Vinayak P. Dravid, Shanthi Kanthala
Publikováno v:
ACS Applied Materials & Interfaces. 8:6953-6961
Magnetic nanostructures (MNS) have emerged as promising functional probes for simultaneous diagnostics and therapeutics (theranostic) applications due to their ability to enhance localized contrast in magnetic resonance imaging (MRI) and heat under e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72bec1459c700aa843d65d9a364ee9a7
https://doi.org/10.1021/acsami.6b01377
https://doi.org/10.1021/acsami.6b01377
Publikováno v:
Future Oncology. 11:865-878
ABSTRACT Expression of the EGF receptors (EGFRs) is abnormally high in many types of cancer, including 25% of lung cancers. Successful treatments target mutations in the EGFR tyrosine kinase domain with EGFR tyrosine kinase inhibitors (TKIs). However
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24fa3f99529ce2d7737548fac4e81b93
https://doi.org/10.2217/fon.14.312
https://doi.org/10.2217/fon.14.312
Autor:
Seetharama D. Jois, Yong-Yu Liu, Gu Xin, Shanthi Kanthala, Sashikanth Banappagari, Ameya Gokhale, Yunfeng Zhao
Publikováno v:
Chemical Biology & Drug Design. 85:702-714
The current approach to treating HER2-overexpressed breast cancer is the use of monoclonal antibodies or a combination of antibodies with traditional chemotherapeutic agents or kinase inhibitors. Our approach is to target clinically validated HER2 do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb24d23990ed5b2307dec407031eb7d2
https://doi.org/10.1111/cbdd.12453
https://doi.org/10.1111/cbdd.12453
Publikováno v:
Biopolymers. 101:693-702
Human epidermal growth factor receptor-2 (HER2) is a tyrosine kinase family protein receptor that is known to undergo heterodimerization with other members of the family of epidermal growth factor receptors (EGFR) for cell signaling. Overexpression o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3172001baaf8aa09dba7409bd2d2f23
https://doi.org/10.1002/bip.22441
https://doi.org/10.1002/bip.22441
Autor:
Paul W. Sylvester, Alaadin Alayoubi, Seetharama D. Satyanarayanajois, Shanthi Kanthala, John F. Anderson, Sami Nazzal
Publikováno v:
Colloids and Surfaces B: Biointerfaces. 103:23-30
The objectives of this work were to engineer physically stable "Vitamin E" rich intravenous lipid emulsions and to evaluate their in vitro antiproliferative activity against MCF-7 (human mammary adenocarcinoma) and SW-620 (human colon adenocarcinoma)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::784e2cdcf40afbdf4def9c333e3d0b74
https://doi.org/10.1016/j.colsurfb.2012.10.003
https://doi.org/10.1016/j.colsurfb.2012.10.003
Publikováno v:
Biopolymers. 101(6)
Human epidermal growth factor receptor-2 (HER2) is a tyrosine kinase family protein receptor that is known to undergo heterodimerization with other members of the family of epidermal growth factor receptors (EGFR) for cell signaling. Overexpression o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d3d7a4fc1a4e0efa101ad1f442219971
https://pubmed.ncbi.nlm.nih.gov/24222531
https://pubmed.ncbi.nlm.nih.gov/24222531